EMG
MED icon

Ellington Management Group’s Medifast MED Stock Holding History

Ellington Management Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,300
Closed -$706K – 272
2020
Q1 		$706K Buy
+11,300
New +$1.03M 0.17% 173
2019
Q4 		– Sell
-10,000
Closed -$1.04M – 671
2019
Q3 		$1.04M Buy
10,000
+6,600
+194% +$709K 0.19% 107
2019
Q2 		$436K Buy
3,400
+300
+10% +$41.7K 0.07% 267
2019
Q1 		$395K Buy
+3,100
New +$393K 0.07% 287
2018
Q3 		– Sell
-1,500
Closed -$240K – 606
2018
Q2 		$240K Sell
1,500
-5,500
-79% -$703K 0.02% 348
2018
Q1 		$654K Buy
+7,000
New +$523K 0.05% 338
2016
Q4 		– Sell
-11,700
Closed -$442K – 706
2016
Q3 		$442K Buy
+11,700
New +$419K 0.12% 317
2013
Q4 		– Sell
-12,900
Closed -$347K – 697
2013
Q3 		$347K Sell
12,900
-11,300
-47% -$302K 0.07% 457
2013
Q2 		$623K Buy
+24,200
New +$636K 0.12% 228

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Ellington Management Group's MED Position: Q2 2020 in Review

Ellington Management Group sold out of Medifast (MED) in Q2 2020, closing a stake of 11,300 shares — an estimated $706K sold.

Ellington Management Group first reported a position in MED in Q2 2013 and held it in 9 quarters. The position peaked at $1.04M in Q3 2019. 224 funds tracked by Wall St. Rank hold MED as of Q2 2020.

  • Ellington Management Group reported no remaining Medifast position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 11,300 Medifast shares in Q2 2020, an estimated $706K.
  • Ellington Management Group first reported a position in Medifast in Q2 2013 and held it in 9 quarters.
  • Ellington Management Group's Medifast position peaked at $1.04M in Q3 2019.
  • 224 funds tracked by Wall St. Rank held Medifast as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.